Hostazym X Improves Aquafeed Utilisation And Environmental Sustainability

reading time
Article | 06.06.2024
Daniel Arana

Ensuring adequate food and nutrition security for a growing global population is still a daunting challenge. Aquaculture has a permanent role in world food security and supply. Globally, food fish consumption has increased annually by around 3.1%, a growth rate which is higher than all other animal protein foods (meat, dairy, milk, etc.), which are increasing by 2.1% each year. On average, world aquaculture production of farmed aquatic animals grew by 5.3% year-on-year.

Alongside aquaculture growth, the aquafeed markets have followed the same fast-growing trend. Recently, aquaculture feed production grew by 3.7% and is estimated to be around 57 million tonnes. Production is dominated by carps, with approximately 28%, followed by tilapia at 18%, marine shrimp at 14.6%, catfish at 11.2%, marine fish at 8.1%, salmon at 6.9%, freshwater crustaceans at 4.6%, other freshwater fish at 3.6%, trout at 2.1%, and other species accounting for 2.9% (Figure 1). 

 

Figure 1. Total estimated aquafeed production per species worldwide

 

Trial in carps

Hostazym X is the only fibre degrading enzyme approved by the European Commission to be used in feed for carp species. It is a highly efficient fibre degrading enzymatic complex which increases nutrient digestibility, resulting in better growth performance and a healthier gut environment.

To challenge Hostazym X, a trial was conducted in an outdoor facility at the University of Poznan, Poland. This trial allowed Hostazym X to be tested under adverse conditions where the water temperature fluctuated from 13.5 to 24.7oC and dissolved oxygen ranged from 2.0 to 5.1 mg/l. As is known, low oxygen levels have a big impact on the feed conversion ratio in fish, and growth and health are impacted.

The trial was set up using three different concentrations of Hostazym X; 1050, 1500 and 3000 EPU/kg feed and compared to a control feed without Hostazym X supplementation. Fish oil at 2% was used to coat the extruded diets with the enzyme. A set of 12 ponds with 40m2 were each stocked with 20 x 375 g fish and fed for 90 days. No mortality was observed over the trial duration.

Hostazym X performance for all three levels of inclusion was better than the control group. The results are presented in Table 1 below and show:

  • Body weight significantly increased compared to the control group
  • Feed conversion rate (FCR) decreased numerically compared to the control group
  • Specific growth rate (SGR) decreased numerically compared to the control group

 

Table 1. Key growth parameters. Different superscripts represent statistical differences at p ≤ 0.05

 

Trial in shrimps

To challenge Hostazym X in crustaceans, a trial was conducted at an outdoor facility at the University of Nakhon Pathom, Thailand. This trial allowed Hostazym X to be tested under farm conditions both alone and in combination with OptiPhos phytase enzyme. Water temperature fluctuated from 27.4 to 29.7oC, dissolved oxygen was above 4 mg/l, salinity around 10 ppt, and total ammonia <1.0 mg/L.

  • The trial was set up to compare three treatments against a control diet without enzyme supplementation (Table 2): 
  • OptiPhos at 1500 FTU/kg feed (PHY)
  • Hostazym X at 3000 EPU/kg (XY)
  • Hostazym X at 3000 EPU/kg feed + OptiPhos at 1500 FTU/kg feed (PHY + XY)

One coating material at 2% was used to coat the pelleted diets with the enzymes. A set of 20 cages with 2 x 1 x 1.5 m were each stocked with 80 juveniles of 2 g ± 0.03 white-leg shrimp (Penaeus vannamei) and fed for 56 days.

 

Table 2. Experimental set-up

 

The results in Figures 2 and 3 show statistical differences between the treatments: 

  • Biomass was higher in the treatments with enzymes added
  • The cages with both OptiPhos and Hostazym X added (TRT4) yielded the highest shrimp biomass per cage, followed by TRT3 (Hostazym X), then TRT2 (OptiPhos) and the lowest yield came from the control group (TRT1)
  • The shrimp in the TRT4 cage grew, on average, by 12.80 g/individual, followed by TRT3 with 12.24 g/individual, then TRT2 with 11.93 g/individual, and the lowest growth was shown in the control treatment group with 10.90 g/individual

 

Figure 2. Shrimp biomass produced per cage over 8 weeks. Different superscripts represent statistical differences at < 0.05

 

Figure 3. Individual shrimp weight per treatment obtained after 8 weeks. Different superscripts represent statistical differences at < 0.05

 

Conclusions

  • Both trials performed in cyprinids (carp) and crustaceans (shrimp) show an improvement in growth with the addition of Hostazym X
  • The biomass of fish and shrimp produced was higher in the treatments with Hostazym X compared to the control group
  • The best result for both species was observed using an inclusion of 3000 EPU/kg feed of Hostazym X
  • The use of Hostazym X in combination with OptiPhos seems to have a positive synergy in the growth and yield of Penaeus vannamei shrimp
global presence

Local support from a global company

Huvepharma® has a distribution network which covers more than 90 countries in 6 continents. Find your nearest Huvepharma® representative today.
Find your local contact
about us

Huvepharma®

Huvepharma® is a fast-growing, global pharmaceutical company with a focus on developing, manufacturing and marketing human and animal health and nutrition products.
more about us

Change country

The Huvepharma® distribution network covers 90 countries in 6 continents. Please select a country from the list below to see the products and services available in that region.

To view all products and services, select Global from the dropdown menu or click .

Africa

Asia

Europe

North America

Oceania

South America

Change language

Huvepharma has a remarkable distribution network which covers 90 countries in 6 continents. To offer you the best services, we ask you to select your country.

Europe

top
Your browser is out of date!

Update your browser to view this website correctly. Update my browser now